Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07764120
Quality of Life of Patients After Rectal Cancer Resection .University Hospital, GrenobleNot Yet Recruiting
NCT07764120Not Yet Recruiting
—
Quality of Life of Patients After Rectal Cancer Resection .University Hospital, Gren...
NCT07762287
Evaluation of Possible Ways the Body May Process Two Different Forms of Elinzanetant in Healthy Study ParticipantsBayerRecruitingPhase 1
NCT07762287Recruiting
Phase 1
Evaluation of Possible Ways the Body May Process Two Different Forms of Elinzane...Bayer
NCT07762404
Reconstruction of First Web Space After Trauma and BurnSohag UniversityNot Yet RecruitingNot Applicable
NCT07762404Not Yet Recruiting
Not Applicable
Reconstruction of First Web Space After Trauma and BurnSohag University
NCT07763054
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia PatientsHaikou Affiliated Hospital of Central South University Xiangya School of MedicineRecruiting
NCT07763054Recruiting
—
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutro...Haikou Affiliated Hospita...
NCT07762664
Photon-Counting CT Versus Conventional CT for Carotid Plaque Assessment in Patients With Carotid Artery StenosisChinese PLA General HospitalRecruiting
NCT07762664Recruiting
—
Photon-Counting CT Versus Conventional CT for Carotid Plaque Assessment in Patie...Chinese PLA General Hospi...
NCT07763301
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic MalignanciesWest China HospitalRecruitingPhase 1
NCT07763301Recruiting
Phase 1
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignan...West China Hospital
NCT07763951
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study.ADIUMCompletedNot Applicable
NCT07763951Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07763262
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha UniversityCompletedNot Applicable
NCT07763262Completed
Not Applicable
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha University
NCT07763574
Effects of Strength Training Combined With Sustainable Source of Omega-3 Fatty Acids on Muscle Strength and Cognitive Functions in Adults Controlled TrialGdansk University of Physical Education and SportEnrolling By InvitationNot Applicable
NCT07763574Enrolling By Invitation
Not Applicable
Effects of Strength Training Combined With Sustainable Source of Omega-3 Fatty A...Gdansk University of Phys...
NCT07763093
Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Class I Gingival RecessionUniversity of Medicine and Pharmacy at Ho Chi Minh CityActive Not RecruitingNot Applicable
NCT07763093Active Not Recruiting
Not Applicable
Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Cla...University of Medicine an...
NCT07762768
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Response in Individuals With PrediabetesCSIR National Institute for Interdisciplinary Science and Technology (NIIST), ThiruvananthapuramNot Yet RecruitingNot Applicable
NCT07762768Not Yet Recruiting
Not Applicable
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Res...CSIR National Institute f...
NCT07762430
Food Noise Survey Development and Validation in Hindi and English-Speaking AdultsDiabetes Foundation, IndiaNot Yet Recruiting
NCT07762430Not Yet Recruiting
—
Food Noise Survey Development and Validation in Hindi and English-Speaking Adult...Diabetes Foundation, Indi...
NCT07764328
This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Balance in Women Who Suffer From Self-reported PCOS Symptoms.Mila Mend Inc.RecruitingNot Applicable
NCT07764328Recruiting
Not Applicable
This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Bal...Mila Mend Inc.
NCT07764042
Effects of Wet Cupping Therapy in Patients With AsthmaMedipol UniversityCompletedNot Applicable
NCT07764042Completed
Not Applicable
Effects of Wet Cupping Therapy in Patients With AsthmaMedipol University
NCT07762911
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)University Hospital, Basel, SwitzerlandRecruitingNot Applicable
NCT07762911Recruiting
Not Applicable
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year...University Hospital, Base...
NCT07763743
Efficacy and Safety of Flexible Ureteroscopy With Flexible Navigable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy With Vacuum-Assisted Access SheathAin Shams UniversityRecruitingNot Applicable
NCT07763743Recruiting
Not Applicable
Efficacy and Safety of Flexible Ureteroscopy With Flexible Navigable Suction Ure...Ain Shams University
NCT07762313
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit in Adolescents With Extremity Arterial Injury.Humacyte, Inc.Not Yet RecruitingPhase 3
NCT07762313Not Yet Recruiting
Phase 3
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular...Humacyte, Inc.
NCT07762547
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.Beijing Tiantan HospitalNot Yet RecruitingNot Applicable
NCT07762547Not Yet Recruiting
Not Applicable
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moy...Beijing Tiantan Hospital
NCT07762885
Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving SurgeryFudan UniversityRecruitingPhase 3
NCT07762885Recruiting
Phase 3
Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma...Fudan University
Result Breakdown
Recruiting8 (40%)
Not yet recruiting7 (35%)
Completed3 (15%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable11 (55%)
Not Specified4 (20%)
Phase 12 (10%)
Phase 32 (10%)
Phase 21 (5%)